UROD

Uroporphyrinogen decarboxylase · P06132 · UROD on Sugi Atlas →

0 patent compounds predicted against UROD, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to UROD by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Genetic Determinants of Amitriptyline Efficiency for Pain Treatment - Part II PHASE4COMPLETED
Genetic Determinants of Amitriptyline Efficiency for Pain Treatment PHASE4COMPLETED
A Phase I/II Open-label Safety and Efficacy Study of LNP.UCD.ABE in Patients With Urea Cycle Disorders. PHASE1/PHASE2NOT_YET_RECRUITING
Study of cPMP (Precusor Z) to Treat Molybdenum Cofactor Deficiency (MoCD) Type A PHASE1/PHASE2WITHDRAWN
Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria PHASE2COMPLETED
Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda PHASE2UNKNOWN
Safety, Tolerability and PK/PD Evaluation of Intravenous Administration of MRT5201 in Patients With OTC Deficiency PHASE1/PHASE2WITHDRAWN
Studies in Porphyria I: Characterization of Enzyme Defects nanUNKNOWN
Risk Factors of Porphyria Cutanea Tarda (PCT) nanCOMPLETED
Nitric Oxide Supplementation on Neurocognitive Functions in Patients With ASLD nanCOMPLETED
Study of the Pathogenesis of Porphyria Cutanea Tarda nanCOMPLETED
Longitudinal Study of the Porphyrias nanRECRUITING
Stone Disease in Children and Their Families nanCOMPLETED
The PRO-FUTURE Project nanRECRUITING
Case Control Study to Investigate the Use of Urethral Pressure Profile Measurement in Children nanNOT_YET_RECRUITING
Vancomycin Associated Red Man Syndrome (RMS) nanCOMPLETED
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders nanRECRUITING
Clinical Diagnosis of Acute Porphyria nanCOMPLETED
Study in Healthy Subjects, Patients With Urea Cycle Disorders (UCD) and Carriers of UCD Mutations to Evaluate Urea Cycle Function nanCOMPLETED
Cystine Capacity Clinical Study (CysCap) nanCOMPLETED
Prevalence of Acute Hepatic Porphyria nanCOMPLETED
Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact nanCOMPLETED
Longitudinal Study of Urea Cycle Disorders nanRECRUITING
Primary Hyperoxaluria Mutation Genotyping/Phenotyping nanCOMPLETED
Chronic Liver Disease in Urea Cycle Disorders nanCOMPLETED
PCORI Urea Cycle Disorder Study nanCOMPLETED
Observational Study of Acute Intermittent Porphyria Patients nanCOMPLETED
Urobilinogen, Maternal Weight Loss and Impending Parturition at Term nanCOMPLETED
Proteomic Study of Urinary Stone Disease nanCOMPLETED
UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis. nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a UROD binder may also engage these)

ProteinNameSimilarity
Q5RDK5 1.000 Q5RDK5 →
Q8HY31 1.000 Q8HY31 →
P32362 0.995 P32362 →
P70697 0.995 P70697 →
Q2JX97 0.993 Q2JX97 →
A6T450 0.992 A6T450 →
P57964 0.991 P57964 →
Q9PTS2 0.991 Q9PTS2 →
Q3J6U6 0.990 Q3J6U6 →
B1WVY1 0.990 B1WVY1 →
Q1R5W3 0.989 Q1R5W3 →
Q2JKH3 0.989 Q2JKH3 →
B2J9R9 0.989 B2J9R9 →
B1LNU9 0.988 B1LNU9 →
A8A797 0.988 A8A797 →
Q3YUY7 0.988 Q3YUY7 →
B7NFT8 0.988 B7NFT8 →
P29680 0.988 P29680 →
C5A0T8 0.988 C5A0T8 →
B5F1I0 0.988 B5F1I0 →
B5FQL2 0.988 B5FQL2 →
Q8XU90 0.988 Q8XU90 →
B2SKP7 0.988 B2SKP7 →
Q123Y6 0.988 Q123Y6 →
B4TCT6 0.988 B4TCT6 →
B1IUQ0 0.988 B1IUQ0 →
A7MJ78 0.988 A7MJ78 →
A4GAF0 0.987 A4GAF0 →
Q4KJI4 0.987 Q4KJI4 →
A1AIG8 0.987 A1AIG8 →